Molecular Mechanisms Linking Nonalcoholic Steatohepatitis to Cancer
Kara Wegermann, Jeongeun Hyun, Anna Mae Diehl – 4 February 2021
Nonalcoholic Steatohepatitis, Sarcopenia, and Liver Transplantation
Rahima A. Bhanji, Yedidya Saiman, Kymberly D. Watt – 4 February 2021
Development and Validation of a Model to Predict Long‐Term Survival After Liver Transplantation
David Goldberg, Alejandro Mantero, Craig Newcomb, Cindy Delgado, Kimberly Forde, David Kaplan, Binu John, Nadine Nuchovich, Barbara Dominguez, Ezekiel Emanuel, Peter P. Reese – 3 February 2021 – Patients are prioritized for liver transplantation (LT) under an “urgency‐based” system using the Model for End‐Stage Liver Disease score. This system focuses solely on waitlist mortality, without considerations of posttransplant morbidity, mortality, and health care use. We sought to develop and internally validate a continuous posttransplant risk score during 5‐year and 10‐year time horizons.
Discovery and Opportunities With Integrative Analytics Using Multiple‐Omics Data
Arjun P. Athreya, Konstantinos N. Lazaridis – 3 February 2021
Living Donor Liver Transplantation for Patients With Hepatocellular Carcinoma: What Are the Optimal Criteria?
Meng Sha, Ying Tong, Qiang Xia – 3 February 2021
Sleep Disturbance Is Associated With the Presence of Portosystemic Collaterals in Patients With Compensated Cirrhosis
Maya Balakrishnan, Caroline Falker, Samantha Conley, Maria Ciarleglio, Yanhong Deng, Nancy S. Redeker, Guadalupe Garcia‐Tsao – 2 February 2021 – Disturbed sleep is common among patients with cirrhosis. The extent to which this is associated with the different stages of compensated cirrhosis is unknown. This study examines whether the presence of portosystemic collaterals, an indicator of clinically significant portal hypertension, is associated with sleep disturbance in compensated cirrhosis.
The Motivations for Donation Among Potential Adolescent Living Donor Liver Transplantation Donors
Harin Kim, Hyo‐Won Kim, Kee Jeong Park – 2 February 2021
Cirrhotic Cardiomyopathy Predicts Posttransplant Cardiovascular Disease: Revelations of the New Diagnostic Criteria
Manhal Izzy, Anna Soldatova, Xin Sun, Mounika Angirekula, Kristin Mara, Grace Lin, Kymberly D. Watt – 2 February 2021 – The diagnostic criteria for cirrhotic cardiomyopathy (CCM) were recently revised to reflect the contemporary advancements in echocardiographic technology. This study evaluates the prevalence of CCM, according to the new criteria, and its impact on posttransplant cardiovascular disease (CVD). This is a single‐center retrospective matched cohort study of liver transplantation (LT) recipients who underwent LT between January 1, 2008 and November 30, 2017.
Reply
Sasha Deutsch‐Link, Ethan M. Weinberg, Therese Bittermann, Marina Serper – 2 February 2021
Nuclear factor erythroid 2–related factor 2 and β‐Catenin Coactivation in Hepatocellular Cancer: Biological and Therapeutic Implications
Junyan Tao, Yekaterina Krutsenko, Akshata Moghe, Sucha Singh, Minakshi Poddar, Aaron Bell, Michael Oertel, Aatur D. Singhi, David Geller, Xin Chen, Amaia Lujambio, Silvia Liu, Satdarshan P. Monga – 1 February 2021